Finance

Lists
TCRT:NASDAQ
Alaunos Therapeutics Inc
$1.51
-3.18%
(-0.050) 1D
Sep 11, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TCRT...
Open
$1.52
High
$1.53
Low
$1.50
Mkt. cap
3.84M
Avg. vol.
11.33K
Volume
18.28K
52-wk high
$4.59
52-wk low
$1.50
EPS
-$1.82
Beta
-0.97
Shares outstanding
2.54M
No. of employees
1
Open
$1.52
High
$1.53
Low
$1.50
Mkt. cap
3.84M
Avg. vol.
11.33K
Volume
18.28K
52-wk high
$4.59
52-wk low
$1.50
EPS
-$1.82
Beta
-0.97
Shares outstanding
2.54M
No. of employees
1
About Alaunos Therapeutics Inc
CEO-
Employees1
Founded1998
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
3.00K
-
-
Cost of goods sold
469.00K
361.00K
427.00K
388.00K
Cost of revenue
469.00K
361.00K
427.00K
388.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
718.00K
549.00K
585.00K
564.00K
Operating expense
718.00K
549.00K
585.00K
564.00K
Total operating expenses
1.19M
910.00K
1.01M
952.00K
Operating income
-1.19M
-907.00K
-1.01M
-952.00K
Other non operating income
28.00K
14.00K
6.00K
-
EBT including unusual items
-1.16M
-893.00K
-1.01M
-952.00K
EBT excluding unusual items
-1.16M
-893.00K
-1.01M
-952.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.16M
-893.00K
-1.01M
-952.00K
Net profit margin
-
-29,766.67%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.19M
-905.25K
-1.00M
-943.00K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps